Given Ultragenyx's mixed past earnings performance and the current positive year-to-date stock performance, the short-term impact of the upcoming earnings report is uncertain. The stock could move in either direction based on whether the company beats the EPS estimate and provides positive future guidance. Historical data shows that the company's stock price can react positively even when missing EPS estimates, suggesting investor focus may be more on guidance than on meeting or beating estimates.